# A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes

> **NCT01008163** · PHASE2 · COMPLETED · sponsor: **Yuyu Pharma, Inc.** · enrollment: 72 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** YY-351/Placebo
- **DRUG:** YY-351/Placebo
- **DRUG:** YY-351
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01008163
- **Lead sponsor:** Yuyu Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01008163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01008163, "A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01008163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*